January 31, 2023
Teijin Pharma on January 30 rolled out its osteoporosis treatment Ostabalo (abaloparatide) in Japan along with a dedicated injector, with the aim of turning it into a core product within its bone and joint disease franchise. Ostabalo is a self-administered...read more